
Photo: NDTV Profit
Business & Finance
Natco Pharma Shares Rally 9% Despite Weak Q2 Results; Details Inside
TL;DR
- Revenue from operations or top line declined 29% YoY to Rs 967 crore in Q2FY27, from Rs 1,363 crore in the year-ago period.
Short summary
Our full write-up is on its way. For the complete story, read the original report:
Nov 15, 2026 · Updated 11/16/2026, 4:25:45 AM · Reported with: NDTV Profit
Sources (1)
NRI Bytes writes its own articles from the reporting below.
NDTV Profit — Natco Pharma Shares Rally 9% Despite Weak Q2 Results; Details InsideUp next · Business & Finance
FirstCry-parent Brainbees Solutions shares rally 13%: Q2 net loss narrows 75%, revenue jumps - Should you buy?
Read next →
More stories
Business & Finance
Meta tightens Instagram content recommendations in India amid govt scrutiny
42m ago
Business & Finance
Which are the top stocks to buy on November 17, 2026?
42m ago

Business & Finance
Paint Companies Announce Second Round Of November Price Hikes As Costs Rise | Profit Exclusive
1h ago

Business & Finance
Who Is Madison Huang? Meet Jensen Huang's Daughter, Her Nvidia Role And Equation With Interim CEO
1h ago


